Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

663
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
663
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

560
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
560

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loading of zinc and iron in grains of different wheat genotypes in the calcareous and floodplain soils of Bangladesh.

Heliyon·2023
Same author

Non-target impacts of pesticides on soil N transformations, abundances of nitrifying and denitrifying genes, and nitrous oxide emissions.

The Science of the total environment·2022
Same author

Exploiting unique structural and functional properties of malarial glycolytic enzymes for antimalarial drug development.

Malaria research and treatment·2015
Same author

Rapid restriction enzyme-free cloning of PCR products: a high-throughput method applicable for library construction.

PloS one·2014
Same author

Novel missense mutation in FHIT gene: interpreting the effect in HPV-mediated cervical cancer in Indian women.

Molecular and cellular biochemistry·2009
Same author

Cystic fibrosis presenting as new onset diabetes mellitus in adolescent twins.

Pediatric diabetes·2004

Related Experiment Video

Updated: Feb 22, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K

Nanotechnology-Based Approach in Tuberculosis Treatment.

Mohammad Nasiruddin1, Md Kausar Neyaz2, Shilpi Das1

  • 1Triesta Sciences, HealthCare Global Enterprises Limited, Bangalore 560 027, India.

Tuberculosis Research and Treatment
|February 18, 2017
PubMed
Summary

Tuberculosis (TB) treatment faces challenges like drug resistance and poor patient compliance. Nanoparticle-based therapies offer a promising solution for more effective and convenient TB treatment.

More Related Videos

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

6.2K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.1K

Related Experiment Videos

Last Updated: Feb 22, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

6.2K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.1K

Area of Science:

  • Infectious Diseases
  • Nanotechnology
  • Pharmaceutical Technology

Background:

  • Tuberculosis (TB) is a leading infectious killer, with drug-resistant strains (MDR and XDR) posing a significant threat.
  • Current TB treatment faces challenges including prolonged duration, high pill burden, and poor patient compliance, hindering effectiveness.
  • The existing BCG vaccine is ineffective against adult pulmonary TB, the most common form of the disease.

Purpose of the Study:

  • To review nanotechnology-based therapies for tuberculosis treatment.
  • To highlight the potential of nanoparticles in overcoming challenges associated with conventional TB drug delivery.

Main Methods:

  • Review of existing literature on nanoparticle-based drug delivery systems for tuberculosis.
  • Evaluation of various nanocarriers and their administration routes for TB therapy.

Main Results:

  • Nanoparticle-based therapies demonstrate promising outcomes for chronic infectious diseases like TB.
  • Controlled and sustained drug release from nanocarriers improves efficacy and reduces dosage frequency.
  • Nanotechnology-based approaches can enhance patient compliance by simplifying treatment regimens.

Conclusions:

  • Nanoparticle-based drug delivery systems represent a significant advancement in TB treatment strategies.
  • These novel approaches can address limitations of current therapies, including drug resistance and poor compliance.
  • Further development of nanotechnology holds potential for more effective and robust tuberculosis management.